15–34 (n = 734) | 35–59 (n = 1593) | ≥60 (n = 2090) | Total (n = 4417) | p-value | |
---|---|---|---|---|---|
Any drug resistance | 118 (16.1%) | 258 (16.2%) | 308 (14.7%) | 684 (15.5%) | 0.426 |
Resistant to | |||||
INH | 82 (11.2%) | 195 (12.2%) | 218 (10.4%) | 495 (11.2%) | 0.226 |
RIF | 63 (8.6%) | 101 (6.3%) | 68 (3.3%) | 232 (5.3%) | 0.000 |
Rfb | 41 (5.6%) | 64 (4.0%) | 41 (2.0%) | 146 (3.3%) | 0.000 |
EMB | 22 (3.0%) | 65 (4.1%) | 44 (2.1%) | 131 (3.0%) | 0.002 |
PZA | 16 (2.2%) | 43 (2.7%) | 30 (1.4%) | 89 (2.0%) | 0.024 |
Km | 4 (0.5%) | 14 (0.9%) | 13 (0.6%) | 31 (0.7%) | 0.558 |
Am | 4 (0.5%) | 11 (0.7%) | 12 (0.6%) | 27 (0.6%) | 0.876 |
Cm | 5 (0.7%) | 12 (0.8%) | 17 (0.8%) | 34 (0.8%) | 0.936 |
Sm | 31 (4.2%) | 61 (3.8%) | 76 (3.6%) | 168 (3.8%) | 0.773 |
Lfx | 15 (2.0%) | 28 (1.8%) | 30 (1.4%) | 73 (1.7%) | 0.495 |
Mfx | 14 (1.9%) | 22 (1.4%) | 28 (1.3%) | 64 (1.4%) | 0.520 |
Ofx | 15 (2.0%) | 27 (1.7%) | 29 (1.4%) | 71 (1.6%) | 0.450 |
Pto | 8 (1.1%) | 14 (0.9%) | 23 (1.1%) | 45 (1.0%) | 0.785 |
Cs | 1 (0.1%) | 3 (0.2%) | 2 (0.1%) | 6 (0.1%) | 0.751 |
PAS | 5 (0.7%) | 24 (1.5%) | 29 (1.4%) | 58 (1.3%) | 0.245 |
INH-monoresistance | 40 (5.4%) | 114 (7.2%) | 162 (7.8%) | 316 (7.2%) | 0.115 |
RIF-monoresistance | 21 (2.9%) | 20 (1.3%) | 12 (0.6%) | 53 (1.2%) | 0.000 |
Multidrug resistance | 42 (5.7%) | 81 (5.1%) | 56 (2.7%) | 179 (4.1%) | 0.000 |
Resistance to any FQsa | 16 (2.2%) | 29 (1.8%) | 30 (1.4%) | 75 (1.7%) | 0.363 |
Resistance to any SLIDsb | 7 (1.0%) | 16 (1.0%) | 19 (0.9%) | 42 (1.0%) | 0.957 |